• Recursion Pharmaceuticals releases open-source 300-gigabyte dataset to improve AI use in biotech

    Salt Lake City-based biotech company Recursion Pharmaceuticals released a dataset of genetically altered cell images on May 6 that can be downloaded at no cost and aims to improve the use of artificial intelligence in drug discovery, STAT reports.
  • How AI helped 2 health systems automate case reviews & reduce claim denials

    Healthcare lags behind other industries when it comes to adopting technologies, and artificial intelligence tools are no exception, according to XSOLIS Chief Medical Officer Heather Bassett, MD.
  • Two studies use AI-generated images to stimulate specific brain neurons

    A pair of studies published this week used artificial intelligence to create images that, when shown to monkeys, were able to target specific brain neurons, giving scientists a clearer understanding of the inner workings of the brain.
  • Study: Deep learning can predict reactions to thrombolysis

    Deep learning models trained to read and analyze CT scans of the brain can help predict patient reactions to intravenous thrombolysis treatments, according to a study published in Academic Radiology on April 30.
  • Machine learning used to detect tuberculosis strains' drug resistance

    A new machine learning model can instantly and accurately predict a tuberculosis strain's potential resistance to first- and second-line drugs, according to a study published in EBioMedicine on April 29.
  • AI-powered kidney disease diagnostic tool receives FDA 'Breakthrough Device' designation

    The first artificial intelligence-enabled device for diagnosing and managing fast-progressing kidney disease has been granted "Breakthrough Device" designation from the FDA, Cardiff, U.K.-based clinical technology company Renalytix AI announced on May 2.
  • Novartis, Pfizer, Centene CEOs on AI's limitations in healthcare

    Though researchers continue to make strides in using artificial intelligence to monitor patient health, identify diseases and analyze imaging tests, executives at pharmaceutical companies such as Novartis and Pfizer are less convinced of the technology's potential in drug discovery, according to The Wall Street Journal.
  • FDA exploring use of AI, blockchain to monitor food safety

    The FDA is launching a new pilot program that will use artificial intelligence to improve monitoring of foodborne illness risk, and is also considering implementing a blockchain network to track food for the same purpose, the agency announced.
  • Accenture uses Google AI to combat loneliness in aging population

    Artificial intelligence is now being used to tackle senior citizens' acute loneliness, which has been shown to accelerate other mental health issues, through a new joint initiative from Accenture and Swedish energy supplier Stockholm Exergi.
  • AstraZeneca partners with machine learning firm for drug discovery

    AstraZeneca announced that it will begin using artificial intelligence in its drug discovery and development efforts through a new partnership with London-based health tech company BenevolentAI.
  • AI-powered smartphone scanner diagnoses diabetic retinopathy on the spot

    Diabetic retinopathy, a condition that takes ophthalmologists up to a week diagnose and can lead to permanent vision loss if untreated, can now be diagnosed within minutes using a smartphone camera integrated with artificial intelligence software, according to the Ann Arbor-based University of Michigan's Michigan Medicine.
  • Y Combinator accelerator will prioritize biotech startups using AI for drug discovery

    Y Combinator, the high-profile startup accelerator based in Mountain View, Calif., announced in a blog post that it will prioritize applicants that are using Atomwise's artificial intelligence software for drug discovery.
  • MIT report calls for the study of 'machine behavior' as technology advances

    A new report authored by researchers at the Massachusetts Institute of Technology in Cambridge and published in the journal Nature outlines the need for the establishment of a new field of study to better understand the abilities, impact and underlying mechanisms of artificial intelligence.
  • Robotic catheter autonomously navigates a beating heart

    Scientists at Harvard Medical School affiliate Boston Children's Hospital have developed a catheter that uses haptic vision and machine learning to self-navigate its way through a still-beating heart, according to a study published in Science Robotics.
  • Viewpoint: How health systems can integrate AI into stroke treatment

    Though artificial intelligence is a hot topic in healthcare, most programs in the discussion are in the very early stages of development or are still mostly theoretical. Baltimore-based LifeBridge Health, however, has already found ways to integrate life-saving machine learning processes into stroke treatment, according to Daniel J. Durand, MD, the health system's chief innovation officer.
  • Cleveland Clinic, Case Western receive $3M NIH grant for machine learning-based imaging analysis

    The National Institutes of Health awarded a $3 million, five-year grant to Cleveland Clinic and Case Western Reserve University, also in Cleveland, to develop a new method of analyzing brain scans captured using magnetic resonance fingerprinting.
  • AI-powered neural decoder can turn thoughts into speech

    A new report in Nature details the efforts of scientists at the University of California's San Francisco and Berkeley campuses to translate brain signals into an approximation of natural speech, a groundbreaking process that, with further development, could restore fluent communication to patients being treated for strokes, paralysis and neurodegenerative diseases like ALS.
  • FDA clears 1st AI smartphone device to detect 3 types of heart arrhythmia

    AliveCor, the Mountain View, Calif.-based artificial intelligence and medtech company, has received FDA clearance for two more analyses on its AI-powered KardiaMobile electrocardiogram (ECG) device.
  • Study: AI used to diagnose rare genetic diseases in children in record timing

    A new study published in Science Translational Medicine describes the work of researchers at San Diego's Rady Children's Institute for Genomic Medicine to rapidly diagnose genetic diseases using whole-genome sequencing.
  • Elon Musk says an update on his neurotech company is 'coming soon'

    Elon Musk, CEO of Tesla and SpaceX, hinted on Twitter that news from Neuralink, the neurotechnology company he founded in 2016, is imminent.

Top 40 Articles from the Past 6 Months